Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New antitumor fredericamycin derivatives discovered at Biofrontera

Feb. 24, 2004

Novartis presents novel tyrosine kinase inhibitors with utility in leukemia

Feb. 24, 2004

New protein kinase inhibitors for cancer therapy designed at Novartis

Feb. 24, 2004

Phase I trial of PT-523 commences enrollment

Feb. 24, 2004

New tubulysin conjugates for cancer therapy claimed by Morphochem

Feb. 24, 2004

Novartis presents new modulators of Smac/IAP interaction

Feb. 24, 2004

Exelixis files IND for XL-647

Feb. 23, 2004

Promising phase II results found for PCK-3145 in advanced prostate cancer

Feb. 23, 2004

IND filing to study Modrenal for prostate cancer

Feb. 20, 2004

Novel antiproliferative CDK inhibitors prepared and tested by Indian scientists

Feb. 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...